Editorial

Insights

Perspectives on intelligence infrastructure, programme design, and technology strategy across our sectors.

Designing Intelligence for Drug Development Programmes

A short perspective on why model quality in life sciences depends as much on programme design and data structure as it does on algorithm choice.

How private capital platforms can evolve from fragmented reporting workflows into continuously improving intelligence infrastructure.